Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IPR-17010452Phase 4Recruiting
Phase 4, randomised trial of ropivacaine in gastrointestinal cancer and gastrointestinal stromal tumor (GIST) (3 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoints: Anal exhaust time and Pain score. Started Feb 2017; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IPR-17010452.